Wordt geladen...
Clinical utility of risedronate in postmenopausal osteoporosis: patient considerations with delayed-release formulation
Bisphosphonates are the most widely prescribed treatment for postmenopausal osteoporosis, secondary osteoporosis, and male osteoporosis. Notwithstanding their high effectiveness and favorable safety profile, the adherence to bisphosphonate treatment remains low. Different treatment strategies aim to...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3333827/ https://ncbi.nlm.nih.gov/pubmed/22532780 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJWH.S18209 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|